Cost-Effectiveness Of Delayed-Release Dimethyl Fumarate Compared To Glatiramer Acetate And Fingolimod For The Treatment Of Relapsing-Remitting Multiple Sclerosis

May 1, 2014, 00:00
10.1016/j.jval.2014.03.356
https://www.valueinhealthjournal.com/article/S1098-3015(14)00407-0/fulltext
Title : Cost-Effectiveness Of Delayed-Release Dimethyl Fumarate Compared To Glatiramer Acetate And Fingolimod For The Treatment Of Relapsing-Remitting Multiple Sclerosis
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00407-0&doi=10.1016/j.jval.2014.03.356
First page : A60
Section Title : Neurological Disorders
Open access? : No
Section Order : 1397
Categories :
Tags :
Regions :
ViH Article Tags :